Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "PL Lodz Watala C"

From Bioblast
Line 11: Line 11:
|city=Lodz
|city=Lodz
|country=Poland
|country=Poland
|MiPNetLab=Watala C, Labieniec M
|MiPNetLab=Watala C, Labieniec M, Siewiera K
|info=[http://www.oroboros.at/?IOC55-56 IOC55-56], [[IOC61]]
|info=[http://www.oroboros.at/?IOC55-56 IOC55-56], [[IOC61]]
}}
}}

Revision as of 15:55, 3 June 2012

Template:MiPNetLab

  • Mitochondrial respiratory capacity nder normal and pathophysiological conditions (diabetes mellitu, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
  • Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
  • targeting of biochemical and molecular burden of diabetes